Advertisement
News
Subscribe to MDT Magazine News

Medtronic to eliminate 1,500 to 2,000 jobs

February 22, 2011 3:45 am | by The Associated Press | Comments

Medtronic, the world's largest medical device maker, says it will lay off up to 2,000 workers as part of a restructuring effort amid sluggish sales of its implants.The company says the cuts are aimed at achieving "long-term sustainable growth" and will reduce its work force by 4 to 5...

Medco Health 4Q profit up 11 percent

February 22, 2011 2:45 am | by The Associated Press | Comments

Medco Health Solutions Inc., the country's largest pharmacy benefits manager, said Tuesday its fourth-quarter profit rose 11 percent, reflecting record volumes in mail-order prescriptions.The Franklin Lakes, N.J., company also reaffirmed its 2011 guidance.For the October-December quarter, the...

Delcath Systems Receives Refusal to File Letter From FDA

February 22, 2011 1:34 am | by Bio-Medicine.Org | Comments

NEW YORK, Feb. 22, 2011 /- Delcath Systems, Inc. (Nasdaq: DCTH ) announced today that the Company has received a "refusal to file" letter from the U.S. Food & Drug Administration (FDA) for the New Drug Application (NDA) for its proprietary chemosaturation system used in the treatment...

TOPICS:
Advertisement

Enox Biopharma, Inc. to Present at IN3 West Investment in Innovation Conference.

February 22, 2011 1:34 am | by Bio-Medicine.Org | Comments

VANCOUVER, British Columbia, Feb. 22, 2011 /- Enox Biopharma, Inc. CEO, John C. Rewcastle, Ph.D., will present at the IN3 West Investment in Innovation Conference on Thursday, February 24 at 11:05 AM PST. The conference is being held at the Venetian Hotel in Las Vegas. Dr. Rewcastle will...

TOPICS:

Avantra Biosciences and MedTrust Online Partner to Develop Clinically Important Protein Biomarker Assays for Improving Cancer Care

February 22, 2011 1:32 am | by Bio-Medicine.Org | Comments

WOBURN, Mass., Feb. 22, 2011 /- MedTrust Online (MedTrust) and Avantra Biosciences (Avantra) announced today a novel collaboration to involve clinicians in the earliest stages of molecular diagnostic assay development for Avantra Biosciences' revolutionary QPDx™ multiplex...

TOPICS:

Johnson & Johnson Completes Tender Offer for Crucell and Declares Offer Unconditional

February 21, 2011 10:36 pm | by Bio-Medicine.Org | Comments

NEW BRUNSWICK, N.J. and LEIDEN, Netherlands, Feb. 22, 2011 /- Johnson & Johnson (NYSE: JNJ ) and Crucell N.V. (NYSE Euronext, Nasdaq: CRXL ; Swiss Exchange: CRX) today announce that Johnson & Johnson has completed the tender offer for Crucell N.V. (Crucell) and has declared the...

TOPICS:

Vaccine made with synthetic gene protects against deadly pneumonia

February 21, 2011 8:35 pm | by EurekAlert | Comments

(Albert Einstein College of Medicine) Researchers at Albert Einstein College of Medicine of Yeshiva University have developed an experimental vaccine that appears to protect against an increasingly common and particularly deadly form of pneumococcal pneumonia. Details of the new vaccine,...

TOPICS:

Higher volume reduces false positives in screening mammography

February 21, 2011 8:35 pm | by EurekAlert | Comments

(Radiological Society of North America) Radiologists who interpret a high volume of mammograms may not detect more cancers but are better at determining which suspicious lesions are not malignant, according to a new study.

TOPICS:
Advertisement

Time to raise how many mammograms radiologists must read?

February 21, 2011 8:34 pm | by EurekAlert | Comments

(Group Health Research Institute) Radiologists who interpret more mammograms and spend some time reading diagnostic mammograms do better at determining which suspicious breast lesions are cancer, according to a new report published online on Feb. 22 and in print in the April issue of...

TOPICS:

Photonics short-listed for UK 'Turing' center

February 21, 2011 7:37 pm | by I-Micronews | Comments

The UK's new technology and innovation centers will be called "Turing Centres", after the World War II code-breaker

Compounds from Tropical Seaweed May be Promising Anti-malarial Drugs

February 21, 2011 12:35 pm | by Georgia Tech Institute of Technology | Comments

A group of chemical compounds used by a species of tropical seaweed to ward off fungus attacks may have promising anti-malarial properties for humans. The compounds are part of a unique chemical signaling system that seaweeds use to battle enemies.

LAB Research loses potential investor, lender places firm into bankruptcy

February 21, 2011 10:45 am | by The Associated Press | Comments

LAB Research Inc. (TSX:LRI) says it has been placed into bankruptcy by its main Canadian lender. The Montreal-area contract research organization says its directors resigned and a receiver was put in charge after a U.S. private equity group informed LAB that it was no longer in interested in...

Univ. of Ariz. starts national civility institute

February 21, 2011 10:45 am | by ALLEN G. BREED - AP National Writer - Associated Press | Comments

Two former presidents — one Republican, the other a Democrat — will chair a new national institute to promote civility in political discourse in the city where U.S. Rep. Gabrielle Giffords was severely wounded in a shooting rampage that left six dead, officials announced Monday.The National...

Sharp's $38M Green Medical Office Building Gets Under Way

February 21, 2011 10:34 am | by San Diego Business Journal | Comments

Sharp Rees-Stealy Medical Group plans to break ground this week on the first green medical office in San Diego, replacing its 85-year-old facility across the street at the corner of Grape Street and Fourth Avenue downtown.

TOPICS:

Biogen's MS drug linked to 10 more brain infection cases

February 21, 2011 9:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Biogen Idec Inc. has disclosed that 10 more patients taking the multiple sclerosis drug Tysabri have contracted the rare brain infection known as PML. The total number of cases of the infection, which can be fatal, is 95, as of Feb. 2.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading